Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BIO · NYSE · Life Sciences Tools & Services
Bio-Rad Laboratories (BIO) · oqro.io/stocks/BIO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$358.90−8.60 (−2.34%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a new position in BIO for Q3 2026SourceInsider trade · Traded Nov 9, 2026 · Filed Nov 12, 2026
Officer sold ~$540K of BIO shares in the open marketSourceInsider trade · Traded Nov 9, 2026 · Filed Nov 12, 2026
Officer sold ~$359K of BIO shares in the open marketSourceInsider trade · Traded Nov 10, 2026 · Filed Nov 12, 2026
Officer sold ~$348K of BIO shares in the open marketSourcePlanned sale · Planned for Nov 10, 2026 · Notice filed Nov 10, 2026
Officer filed to sell about $348K of BIO stockSourcePlanned sale · Planned for Nov 9, 2026 · Notice filed Nov 9, 2026
Officer filed to sell about $540K of BIO stockSourcePlanned sale · Planned for Nov 9, 2026 · Notice filed Nov 9, 2026
Officer filed to sell about $359K of BIO stockSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates no longer reported BIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ariel Investments, LLC disclosed an increased position in BIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
First Pacific Advisors, LP disclosed a reduced position in BIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Freestone Grove Partners LP disclosed a reduced position in BIO for Q2 2026Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Boston Trust Walden Corp disclosed an increased position in BIO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a new position in BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Freestone Grove Partners LP disclosed an increased position in BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Earnest Partners LLC disclosed a reduced position in BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Veritas Asset Management LLP no longer reported BIO for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 18, 2026
Fuller & Thaler Asset Management, Inc. disclosed an increased position in BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ilex Capital Partners (UK) LLP no longer reported BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Veritas Asset Management LLP disclosed a reduced position in BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
First Pacific Advisors, LP disclosed an increased position in BIO for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Select Equity Group, L.P. no longer reported BIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ariel Investments, LLC disclosed a reduced position in BIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ilex Capital Partners (UK) LLP disclosed a reduced position in BIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Bridgewater Associates disclosed a new position in BIO for Q3 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 15, 2025
Earnest Partners LLC disclosed an increased position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Ilex Capital Partners (UK) LLP disclosed an increased position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Ariel Investments, LLC disclosed an increased position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Select Equity Group, L.P. disclosed a reduced position in BIO for Q2 2025Fund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Ariel Investments, LLC disclosed an increased position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deerfield Management Company, L.P. disclosed an increased position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Veritas Asset Management LLP disclosed a reduced position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Select Equity Group, L.P. disclosed a reduced position in BIO for Q1 2025Fund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Apr 14, 2025
Wedge Capital Management L L P no longer reported BIO for Q1 2025SourceInsider trade · Traded Mar 14, 2025 · Filed Mar 18, 2025
Officer sold ~$741K of BIO shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ariel Investments, LLC disclosed an increased position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Select Equity Group, L.P. disclosed a reduced position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Earnest Partners LLC disclosed an increased position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Bellevue Group AG disclosed a reduced position in BIO for Q4 2024Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Jan 31, 2025
Kornitzer Capital Management Inc disclosed an increased position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Jan 15, 2025
Wedge Capital Management L L P disclosed a new position in BIO for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Bellevue Group AG disclosed a reduced position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Select Equity Group, L.P. disclosed an increased position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
Ariel Investments, LLC disclosed an increased position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Ninety One UK Ltd no longer reported BIO for Q3 2024Fund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Oct 29, 2024
Veritas Asset Management LLP disclosed a reduced position in BIO for Q3 2024SourcePolitician trade (House) · Transaction Sep 8, 2023 · Disclosed Oct 10, 2023
Disclosed sale of BIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Jun 29, 2023 · Disclosed Jul 28, 2023
Disclosed purchase of BIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Jun 28, 2023 · Disclosed Jul 28, 2023
Disclosed purchase of BIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Nov 30, 2022 · Disclosed Dec 29, 2022
Disclosed sale of BIO — reported range $1,001 - $15,000SourcePolitician trade (Senate) · Transaction Mar 30, 2022 · Disclosed Apr 8, 2022
Disclosed sale of BIO — reported range $1,001 - $15,000SourcePolitician trade (Senate) · Transaction Mar 29, 2021 · Disclosed Jul 23, 2021
Disclosed purchase of BIO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Jan 5, 2021 · Disclosed Feb 10, 2021
Disclosed partial sale of BIO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Earnest Partners LLC disclosed a reduced position in BIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 7, 2026
Mawer Investment Management Ltd. disclosed a reduced position in BIO for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Fuller & Thaler Asset Management, Inc. no longer reported BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Ariel Investments, LLC disclosed an increased position in BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
First Pacific Advisors, LP disclosed an increased position in BIO for Q1 2026SourceInsider trade · Traded May 11, 2026 · Filed May 13, 2026
Officer sold ~$136K of BIO shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 11, 2026
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 6, 2026
Mawer Investment Management Ltd. disclosed a reduced position in BIO for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Bridgewater Associates no longer reported BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Ariel Investments, LLC disclosed a reduced position in BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 10, 2026
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 10, 2026
Mawer Investment Management Ltd. disclosed a reduced position in BIO for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
First Pacific Advisors, LP disclosed an increased position in BIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 12, 2025
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q3 2025SourceInsider trade · Traded Nov 6, 2025 · Filed Nov 10, 2025
Officer sold ~$214K of BIO shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 4, 2025
Veritas Asset Management LLP disclosed a reduced position in BIO for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 4, 2025
Mawer Investment Management Ltd. disclosed a reduced position in BIO for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 7, 2025
Veritas Asset Management LLP disclosed a reduced position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 7, 2025
Mawer Investment Management Ltd. disclosed a reduced position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 6, 2025
Thompson Siegel & Walmsley LLC disclosed an increased position in BIO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 1, 2025
First Pacific Advisors, LP disclosed an increased position in BIO for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Earnest Partners LLC disclosed a reduced position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 9, 2025
Westfield Capital Management Co LP disclosed a reduced position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 9, 2025
Thompson Siegel & Walmsley LLC disclosed an increased position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 7, 2025
Mawer Investment Management Ltd. disclosed an increased position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 6, 2025
First Pacific Advisors, LP disclosed an increased position in BIO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 2, 2025
Kornitzer Capital Management Inc disclosed a reduced position in BIO for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 12, 2025
Mawer Investment Management Ltd. disclosed an increased position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Westfield Capital Management Co LP disclosed an increased position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 10, 2025
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 4, 2025
Veritas Asset Management LLP disclosed a reduced position in BIO for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Thompson Siegel & Walmsley LLC disclosed a reduced position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Westfield Capital Management Co LP disclosed an increased position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 7, 2024
Mawer Investment Management Ltd. disclosed an increased position in BIO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 4, 2024
First Pacific Advisors, LP disclosed a reduced position in BIO for Q3 2024Source